Buscador de Publicaciones

Grupo Autor Título Original / Colaboración Año Cuartil Tipo Revista

Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells

Autores: Torres, C; Linares, A; Alejandre, MJ; Palomino-Morales, RJ; Delgado, JR; Perales, S

SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma

Autores: Duran, I; Hagen, C; Arranz, JA; Apellaniz-Ruiz, M; Perez-Valderrama, B; Sala, N; Lainez, N; Garcia-Del Muro, X; Nogueron, E; Climent, MA; Maroto, P; Font, A; Garcia-Donas, J; Gallardo, E; Lopez-Criado, P; Del Alba, AG; Saez, MI; Vazquez, S; Luque, R; Rodriguez-Antona, C

Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial

Autores: Balana, C; De Las Penas, R; Sepulveda, JM; Gil-Gil, MJ; Luque, R; Gallego, O; Carrato, C; Sanz, C; Reynes, G; Herrero, A; Ramirez, JL; Perez-Segura, P; Berrocal, A; Vieitez, JM; Garcia, A; Vazquez-Estevez, S; Peralta, S; Fernandez, I; Henriquez, I; Martinez-Garcia, M; De la Cruz, JJ; Capellades, J; Giner, P; Villa, S

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

Autores: Molina, D; Perez-Beteta, J; Martinez-Gonzalez, A; Sepulveda, JM; Peralta, S; Gil-Gil, MJ; Reynes, G; Herrero, A; De Las Penas, R; Luque, R; Capellades, J; Balana, C; Perez-Garcia, VM

Pharmacogenetic predictors of toxicity to platinum based chemotherapy in non-small cell lung cancer patients

Autores: Perez-Ramirez, C; Canadas-Garre, M; Alnatsha, A; Villar, E; Delgado, JR; Faus-Dader, MJ; Calleja-Hernandez, MA

Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

Autores: Morillo, ED; Mesia, R; Klain, JCA; Fernandez, SV; Martinez-Galan, J; Borgonon, MP; Gonzalez-Rivas, C; Daroqui, JC; Berrocal, A; Martinez-Trufero, J; Vera, R; Cruz-Hernandez, JJ

Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines

Autores: Capellades, J; Teixidor, P; Villalba, G; Hostalot, C; Plans, G; Armengol, R; Medrano, S; Estival, A; Luque, R; Gonzalez, S; Gil-Gil, M; Villa, S; Sepulveda, J; Garcia-Mosquera, JJ; Balana, C

< 1 2 … 1.635 1.636 1.637 … 1.706 1.707 >